We are live on ! Find out more
MORF

Morphic Holding, Inc. Common Stock

Delisted

MORF was delisted on the 15th of August, 2024.

103 hedge funds and large institutions have $1.13B invested in Morphic Holding, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

9% less funds holding

Funds holding: 113103 (-10)

11% less capital invested

Capital invested by funds: $1.27B → $1.13B (-$142M)

13% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 38

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
103
Holders Change
-10
Holders Change %
-8.85%
% of All Funds
1.62%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
15
Increased
33
Reduced
38
Closed
24
Calls
$486K
Puts
Net Calls
+$486K
Net Calls Change
-$661K
Name Holding Trade Value Shares
Change
Change in
Stake
SFI
51
Susquehanna Fundamental Investments
Pennsylvania
$699K +$118K +2,812 +19%
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$679K -$143K -3,428 -17%
Millennium Management
53
Millennium Management
New York
$652K -$986K -23,549 -59%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$602K +$209 +5 +0%
AI
55
Atom Investors
Texas
$563K -$30.1K -720 -5%
Deutsche Bank
56
Deutsche Bank
Germany
$537K -$56.3K -1,345 -9%
CS
57
Credit Suisse
Switzerland
$524K +$41K +979 +8%
Citigroup
58
Citigroup
New York
$495K -$1.45M -34,687 -74%
MIM
59
MetLife Investment Management
New Jersey
$489K +$188K +4,491 +58%
MAM
60
Martingale Asset Management
Massachusetts
$479K
Two Sigma Advisers
61
Two Sigma Advisers
New York
$474K -$285K -6,800 -37%
UBS AM
62
UBS AM
Illinois
$471K
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
$461K -$599K -14,300 -55%
HS
64
HighVista Strategies
Massachusetts
$438K -$537K -12,834 -54%
AIG
65
American International Group
New York
$422K -$30.9K -739 -7%
Wells Fargo
66
Wells Fargo
California
$416K -$318K -7,598 -42%
CSS
67
Cubist Systematic Strategies
Connecticut
$413K -$169K -4,030 -28%
Allspring Global Investments
68
Allspring Global Investments
North Carolina
$389K -$18.7K -446 -4%
IA
69
IndexIQ Advisors
New York
$389K +$406K +9,694 New
Invesco
70
Invesco
Georgia
$382K +$9.71K +232 +2%
VOYA Investment Management
71
VOYA Investment Management
Georgia
$343K +$14.4K +344 +4%
EAM
72
Erste Asset Management
Austria
$343K +$356K +8,500 New
ProShare Advisors
73
ProShare Advisors
Maryland
$313K -$85K -2,030 -21%
Legal & General Group
74
Legal & General Group
United Kingdom
$304K +$7.2K +172 +2%
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$222K -$231K -5,527 -50%

MORF Hedge Fund Activity: Q1 2022 in Review

103 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Morphic Holding, Inc. Common Stock (MORF) for Q1 2022, worth a combined $1.13B — down 11% from $1.27B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of MORF and 15 opened new positions — a net loss of 9 holders — while 38 trimmed existing stakes and 33 added.

The largest buyer was Holocene Advisors, adding an estimated $18.7M. The largest seller was Novo Holdings A/S, cutting an estimated $17.4M.

  • 103 institutional investors held Morphic Holding, Inc. Common Stock (MORF) as of Q1 2022, down from 113 in Q4 2021.
  • Funds reported $1.13B of Morphic Holding, Inc. Common Stock stock for Q1 2022, down 11% quarter-over-quarter.
  • 15 funds opened new Morphic Holding, Inc. Common Stock positions in Q1 2022 and 24 closed out, a net change of -9 holders.
  • The largest Morphic Holding, Inc. Common Stock buyer in Q1 2022 was Holocene Advisors, an estimated $18.7M added.
  • The largest Morphic Holding, Inc. Common Stock seller in Q1 2022 was Novo Holdings A/S, an estimated $17.4M sold.

Based on aggregated 13F filings for Q1 2022.